U.S. Renewable Energy Stock News

In early June 2026, uniQure disclosed that the FDA had rejected its data package for accelerated approval of AMT-130 in Huntington’s disease, instead advising a new, lengthy Phase III sham-controlled trial that will delay any potential path to market. This shift forces uniQure to reconsider the role of AMT-130 as its lead value driver, given the extended timelines, higher costs, and added clinical and regulatory uncertainty. We’ll now examine how the FDA’s push for a new Phase III...

American Financial Group (AFG) recently reported core net operating earnings per share rising 17% year over year, beating consensus estimates. The company also declared a US$1.50 special dividend that highlights its current capital strength. See our latest analysis for American Financial Group. At a share price of US$131.28, AFG’s recent price action has been relatively steady, with a 7 day share price return of 1.94% and a 90 day share price return of 3.13%. The 1 year total shareholder...

Stock performance snapshot and recent context Revolve Group (RVLV) has seen mixed share performance recently, with the stock up 3.7% over the past day and 5.8% over the past week, but down over the past month and past 3 months. Year to date the stock is down 31.4%, with the 1 year total return down 7.1%. Over longer periods, the 3 year total return is 20.6%, while the 5 year total return is down 63.1%. At the last close of US$20.27, Revolve Group carries a market value of about US$1.4b. The...

Compañía de Minas Buenaventura S.A.A. has recently benefited from a broad upswing in global metals prices, particularly copper, silver, and gold, while advancing its Peruvian asset base with projects such as the Yumpag mine, expected to lift silver output from 2025. This combination of stronger commodity pricing and mine expansion plans has brought renewed attention to Buenaventura as a leveraged play on cyclical metals exposure and long-term copper and silver demand. We’ll now examine how...

Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare Advantage payment rates. See our latest analysis for Elevance Health. The recent earnings beat and higher 2026 EPS guidance have coincided with strong momentum, with Elevance Health’s 90 day share price return of 46.46% and a 1 year total shareholder return of 12.87% suggesting sentiment has...

Why Li Auto’s May deliveries matter for the stock Li Auto (NasdaqGS:LI) released May 2026 delivery data that fell short of investor expectations, as units declined from April and the prior year, while Chinese EV price competition and changing incentives weighed on sentiment. See our latest analysis for Li Auto. The May delivery shortfall and softer second quarter guidance have come alongside a share price of $14.11, with the stock down 21.61% on a 1 month share price return basis and total...

In early June 2026, Hasbro Inc. launched Sixth Wall, an AI studio that uses proprietary CharacterOS technology and a partnership with ElevenLabs to license how iconic characters like Optimus Prime and Mr. Potato Head think, speak, and interact across interactive experiences. By introducing Behavioral Licensing and a formal talent participation model, Hasbro is seeking to protect character authenticity and rights while opening new AI-driven commercial uses for its franchises. Next, we’ll...

Short term and recent performance snapshot Alliant Energy (LNT) has drawn attention after a recent positive day, with the stock closing at $72.37, up about 0.9% over the past day and almost 2% over the past week. Over the past month the stock shows a gain of about 0.9%, and over the past 3 months it is up roughly 2.2%. Year to date, the total return figure provided is 10.3%, with a 1 year total return of 22.6%. See our latest analysis for Alliant Energy. The recent 1 day share price return of...

Autoliv Innovation Center: why this expansion matters for ALV stock Autoliv (ALV) has opened its new Innovation Center in Vårgårda, Sweden, bringing research, system architecture, testing, prototyping, and pilot production into one hub to support next generation mobility safety solutions. See our latest analysis for Autoliv. Recent trading has been choppy, with the share price down 1.63% over the last day and 4.21% over the past week. However, the 90 day share price return of 17.20% alongside...

Masimo at a glance Masimo (MASI) has been drawing attention after a period of strong year to date share performance, prompting investors to reassess how its current valuation lines up with its healthcare focused revenue base and profitability. See our latest analysis for Masimo. At a share price of $179.95, Masimo has recorded a 41.25% year to date share price return. The 1 year total shareholder return of 7.09% and 5 year total shareholder return decline of 19.88% present a mixed longer term...

Why Element Solutions (ESI) is Drawing Attention Now Element Solutions (ESI) has recently outpaced the broader Basic Materials sector, and analysts have revised full year earnings estimates upward, a combination that is helping focus investor attention on the stock. See our latest analysis for Element Solutions. Recent trading tells a story of strong momentum with some near term cooling. The share price is up 59.1% year to date and the 1 year total shareholder return is 89.2%, even after a 6%...

In recent weeks, analysts have raised their fair value estimate for Weatherford International, citing an improved outlook for revenue growth and higher expected profit margins despite ongoing international market softness and payment delays in regions such as Mexico. This reassessment highlights how Weatherford’s enhanced business fundamentals are being weighed against execution risks in key overseas markets, which could influence how investors interpret its long-term potential. We’ll now...

In early June 2026, Live Oak Bancshares reported first-quarter earnings that exceeded analyst expectations on EPS, declared upcoming cash dividends, and saw its stock move alongside a broader rally in regional banks supported by favorable interest rate conditions. At the same time, CEO James Mahan III sold 20,000 shares worth about US$737,000 under a pre-arranged Rule 10b5-1 plan, while still holding over 6.2 million shares, underscoring that the transaction appears more like routine...

Apollo Global Management (NYSE:APO) ended its £1.52b takeover talks for UK engineering group Bodycote. The firm also launched a new AI compute infrastructure platform alongside Broadcom and Blackstone. The AI platform is aimed at supporting leading AI labs and large scale data center expansion. Apollo Global Management, trading at about $132.7, has seen its stock rise 83.1% over 3 years and 153.1% over 5 years, while the 1 year move is close to flat, down 0.6%. Shorter term performance is...

Immunocore Holdings recently reported updated Phase 1/2 data for its ImmTAC molecule brenetafusp in heavily pretreated advanced melanoma, showing encouraging survival and disease control outcomes that informed selection of a 160 mcg dose for its ongoing Phase 3 PRISM-MEL-301 trial. The results presented at ASCO 2026 also suggested potential benefit in patients with primary PD-1 resistance and hinted at further upside from combinations, including with IL7, which could broaden the future role...

In early June 2026, Credo Technology Group Holding reported fourth-quarter sales of US$437.0 million and net income of US$169.1 million, with full-year sales reaching US$1.34 billion and net income of US$472.28 million, alongside guidance for first-quarter 2027 revenue of US$465.0 million to US$475.0 million. The results highlight how accelerating AI infrastructure demand and an expanding optical connectivity portfolio, reinforced by the Dust Photonics acquisition, are reshaping Credo’s...

UFP Industries (UFPI) is back in focus after Q1 2026 results showed an 8% revenue decline and lower earnings per share, followed shortly by the announcement of a new share repurchase program of up to US$300 million. See our latest analysis for UFP Industries. Despite the Q1 setback and fresh buyback news, the stock has been under pressure this year, with the share price return down 9.47% year to date and the 1 year total shareholder return down 15.49%. However, the 5 year total shareholder...

Why Brown-Forman’s latest earnings have refocused attention on the stock Brown-Forman (BF.B) is back in the spotlight after a mixed fourth quarter, with sales ahead of expectations but profitability under pressure, paired with cautious guidance for fiscal 2027 and a fresh analyst upgrade. See our latest analysis for Brown-Forman. The share price has moved unevenly, with a 7.18% 7 day share price return and a 10.36% 90 day share price return. However, a 5 year total shareholder return that has...

Wondering if MGM Resorts International at around US$47.15 is still offering value after a strong run, or if most of the opportunity has already been priced in. The stock has pulled back about 2.5% over the past week, but sits up 21.6% over 30 days, 29.2% year to date and 41.2% over the last year, which can change how investors think about both upside potential and risk. Recent headlines around MGM often focus on its role as a major integrated resort and casino operator and on broader sector...

Alphatec Holdings (ATEC) is back in focus after missing Q1 2026 revenue estimates, cutting its full year outlook on softer deliveries, and facing fresh securities law investigations that have sharpened investor attention. See our latest analysis for Alphatec Holdings. Despite the legal overhang and guidance cut, the recent 7 day share price return of 10.43% and 30 day share price return of 9.84% sit against a much weaker 90 day share price return, which is down 34.76%, and a year to date...

Covista (CVSA) drew investor attention after first quarter results topped analyst expectations on both revenue and adjusted earnings, with the stock moving 8.1% higher even as education services peers showed mixed outcomes. See our latest analysis for Covista. That earnings jump sits within a wider move where Covista’s share price is up 24.7% over the past 90 days and 20.7% year to date, while the 3 year total shareholder return is very large, suggesting momentum has been building over...

Recent commentary on high response rates and full enrollment in Immunovant (IMVT)'s Phase 2 rheumatoid arthritis trial for IMVT-1402 has focused investor attention on whether this engagement in a difficult-to-treat population justifies the stock’s recent momentum. See our latest analysis for Immunovant. That trial update lands on top of solid momentum in the stock, with a 30 day share price return of 9.23% and a 1 year total shareholder return of 88.83%. This points to building enthusiasm...

In recent days, Wells Fargo downgraded Commercial Metals Company (CMC) from Overweight to Equal Weight, citing concerns about rebar oversupply, weak construction demand, and the stock trading at a peak earnings multiple. This shift in analyst stance highlights how sector-specific supply pressures and softness in housing and infrastructure can quickly reshape sentiment around metals producers. With those concerns about rebar oversupply now on the table, we’ll examine how they affect...

Over the last 7 days, the United States market has dropped 3.3%, yet it remains up 22% over the past year with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying stocks that are potentially priced below their intrinsic value can offer opportunities for investors seeking long-term growth, such as Coastal Financial and two other noteworthy companies.